With its active pharmaceutical ingredient (API) facility “in a state of disrepair,” manufacturer Aspen Biopharma Labs’ operations have ground to a halt in the U.S., according to a recent FDA reprim | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback